Clinical experiences of pulmonary and bloodstream nocardiosis in two tertiary care hospitals in northern Taiwan, 2000-2004

Journal of Microbiology, Immunology and Infection

Volumn 41, Issue 2, 2008, Pages 130-136

  Tuo, Ming Huang ^a,b   Tsai, Ying Huang ^c   Tseng, Hsiang Kuang ^a   Wang, Wei Sheng ^a   Liu, Chang Pan ^a,d   Lee, Chun Ming ^a,d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b Ten Chen Hospital Chungli   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d NURSING AND MANAGEMENT COLLEGE   (Taiwan)

Author keywords

Bacteremia; Lung diseases; Nocardia infections; Opportunistic infections; Risk factors

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CEFUROXIME; COTRIMOXAZOLE; IMIPENEM; MEROPENEM; PREDNISOLONE; TRIMETHOPRIM;

AGED; ARTICLE; BLOOD FLOW; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; DRUG TREATMENT FAILURE; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; LABORATORY TEST; LOWER RESPIRATORY TRACT INFECTION; LUNG INFECTION; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; NOCARDIOSIS; PATIENT TRANSPORT; RECURRENCE RISK; RECURRENT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; STEROID THERAPY; TAIWAN; TERTIARY HEALTH CARE; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC DISEASES; HOSPITALIZATION; HOSPITALS; HUMANS; IMMUNOCOMPROMISED HOST; LUNG DISEASES; MALE; NOCARDIA; NOCARDIA INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; TREATMENT OUTCOME;

EID: 48649084536     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Saubolle MA, Sussland D. Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol. 2003;41: 4497-501.
2. Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ Jr. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006;19:259-82.
3. Menéndez R, Cordero PJ, Santos M, Gobernado M, Marco V. Pulmonary infection with Nocardia species: a report of 10 cases and review. Eur Respir J. 1997;10:1542-6.
4. Hui CH, Au VW, Rowland K, Slavotinek JP, Gordon DL. Pulmonary nocardiosis re-visited: experience of 35 patients at diagnosis. Respir Med. 2003;97:709-17.
5. Esteban J, Ramos JM, Fernandez-Guerrero ML, Soriano F. Isolation of Nocardia sp. from blood cultures in a teaching hospital. Scand J Infect Dis. 1994;26:693-6.
6. Tuo MH, Wu YK, Huang SF, Tsai YH. Disseminated Nocardia farcinica presenting as diffused pulmonary nodular infiltration in a patient with pemphigus vulgaris - a case report. Thorac Med. 2007;22:40-6.
7. Valenzuela-Tovar JF, Contreras-Pérez C, Shibayama-Hernández H, Chávez-González L, Vázquez-Chacón CA, Olivera-Díaz Ft. Biochemical identification and molecular characterization (PCR-RFLP) of Nocardia isolates from sputum. Arch Med Res. 2005;36:356-61.
8. Couble A, Rodríguez-Nava V, de Montclos MP, Boiron P, Laurent F. Direct detection of Nocardia spp. in clinical samples by a rapid molecular method. J Clin Microbiol. 2005;43:1921-4.
9. Wauters G, Avesani V, Charlier J, Janssens M, Vaneechoutte M, Delmée M. Distribution of Nocardia species in clinical samples and their routine rapid identification in the laboratory. J Clin Microbiol. 2005;43:2624-8.
10. Chou WR, Hsueh PR, Chen KY, Kuo SH, Yang PC. Clinical manifestations and outcomes of pulmonary nocardiosis in a teaching hospital in Taiwan. Thorac Med. 2005;20:180-9.
11. Kontoyiannis DP, Jacobson KL, Whimbey EE, Rolston KV, Raad II. Central venous catheter-associated Nocardia bacteremia: an unusual manifestation of nocardiosis. Clin Infect Dis. 2000;31:617-8.
12. Lui WY, Lee AC, Que TL. Central venous catheter-associated Nocardia bacteremia. Clin Infect Dis. 2001 ;33:1613-4.
13. Lai CH, Chi CY, Chen HP, Lai CJ, Fung CP, Liu CY. Port-A catheter-associated Nocardia bacteremia detected by gallium inflammation scan: a case report and literature review. Scand J Infect Dis. 2004;36:775-7.
14. Torres HA, Reddy BT, Raad II, Tarrand J, Bodey GP, Hanna HA, et al. Nocardiosis in cancer patients. Medicine (Baltimore). 2002;81:388-97.
15. Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. New York: Churchill Livingstone; 2005.
16. Hitti W, Wolff M. Two cases of multidrug-resistant Nocardia farcinica infection in immunosuppressed patients and implications for empiric therapy. Eur J Clin Microbiol Infect Dis. 2005;24:142-4.
17. Wallace RJ Jr, Tsukamura M, Brown BA, Brown J, Steingrube VA, Zhang YS, et. al. Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica. J Clin Microbiol. 1990;28:2726-32.
18. Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW, Wallace RJ Jr. In vitro activities of linezolid against multiple Nocardia species. Antimicrob Agents Chemother. 2001;45:1295-7.
19. Moylett EH, Pacheco SE, Brown-Elliott BA, Perry TR, Buescher ES, Birmingham MC, et al. Clinical experience with linezolid for the treatment of Nocardia infection. Clin Infect Dis. 2003;36:313-8.